Experience with etanercept in an academic medical center: Are infection rates increased?
Open Access
- 7 February 2002
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 47 (1), 17-21
- https://doi.org/10.1002/art1.10243
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulentMycobacterium aviumThe Journal of Pathology, 1999
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (Tnfr: Fc) in Rheumatoid ArthritisAnnals of Pharmacotherapy, 1997
- Characterization of tumor necrosis factor-deficient miceProceedings of the National Academy of Sciences, 1997
- Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.The Journal of Experimental Medicine, 1996
- Mortality in rheumatoid arthritisSeminars in Arthritis and Rheumatism, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993